Related Experiment Videos

PRK1 phosphorylates MARCKS at the PKC sites: serine 152, serine 156 and serine 163

R H Palmer1, D C Schönwasser, D Rahman

  • 1Protein Phosphorylation Laboratory, Imperial Cancer Research Fund, London, UK.

FEBS Letters
|January 15, 1996
PubMed

Insights

The 80kDa Myristolated Alanine-Rich C-Kinase Substrate (MARCKS) is phosphorylated by both protein kinase C (PKC) and the related kinase PRK1. This finding suggests MARCKS signaling may involve both PKC and PRK pathways.

Area of Science:

  • Cellular signaling pathways
  • Protein kinase research
  • Molecular biology

Background:

  • The 80kDa Myristolated Alanine-Rich C-Kinase Substrate (MARCKS) is a key substrate for protein kinase C (PKC) in vivo.
  • Understanding MARCKS regulation is crucial for comprehending cellular processes influenced by PKC.

Purpose of the Study:

  • To investigate the role of the PKC-related kinase 1 (PRK1) in phosphorylating MARCKS.
  • To determine if PRK1 phosphorylates MARCKS at the same sites as PKC.
  • To explore the implications of PRK1 involvement in MARCKS signaling.

Main Methods:

  • Analysis of cell extracts to identify MARCKS phosphorylation.
  • In vitro kinase assays using PRK1 and MARCKS.
  • Site-directed mutagenesis or peptide mapping to confirm phosphorylation sites.

Main Results:

  • MARCKS was identified as a major substrate for the lipid-activated PRK1 in cell extracts.
  • PRK1 was demonstrated to phosphorylate MARCKS on the same sites as PKC in vitro.
  • This indicates that PRK1 can regulate MARCKS phosphorylation at previously identified 'PKC' sites.

Conclusions:

  • MARCKS phosphorylation is potentially regulated by both PKC and PRK signaling pathways.
  • MARCKS may serve as a convergence point for multiple kinase-mediated signaling cascades.
  • The findings expand our understanding of MARCKS as a biomarker and signaling hub.

Related Concept Videos